CD19 variants
US-11891426-B2 · Feb 6, 2024 · US
This page is not indexed by search engines while we improve data quality.
Lobb Roy patents
Lobb Roy is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lobb Roy |
| Total patents | 6 |
| First publication | Nov 1, 2018 |
| Latest publication | Feb 6, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Targeted cancer therapy
US-2022313720-A1 · Oct 6, 2022 · US
Targeted cancer therapy
US-11207339-B2 · Dec 28, 2021 · US
Cd19 variants
US-2021079060-A1 · Mar 18, 2021 · US
Protein kinase conjugates and inhibitors
US-10662195-B2 · May 26, 2020 · US
Targeted cancer therapy
US-2018311374-A1 · Nov 1, 2018 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Aleta Biotherapeutics Inc | 5 |
| Us Health | 3 |
| Univ Minnesota | 2 |
| Celgene Avilomics Res Inc | 1 |
| Celgene Car Llc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 6 |
| A61K40/31 | 5 |
| A61K40/11 | 5 |
| C07K2319/03 | 5 |
| C07K14/7051 | 5 |